Tan, WS;
Rodney, S;
Lamb, B;
Feneley, M;
Kelly, J;
(2016)
Management of non-muscle invasive bladder cancer: a comprehensive analysis of guidelines from the United States, Europe and Asia.
Cancer Treatment Reviews
, 47
pp. 22-31.
10.1016/j.ctrv.2016.05.002.
Preview |
Text
Tan et al 2016 Management of non-muscle invasive bladder cancer Uncorrected Proof.pdf Download (1MB) | Preview |
Abstract
Bladder cancer is the 8th most common cancer with 74,000 new cases in the United States in 2015. Non-muscle invasive bladder cancer (NMIBC) accounts for 75% of all bladder cancer cases. Transurethral resection and intravesical treatments remain the main treatment modality. Up to 31-78% of cases recur, hence the need for intensive treatment and surveillance protocols which makes bladder cancer one of the most expensive cancers to manage. The purpose of this review is to compare contemporary guidelines from Europe, (European Association of Urology), the United States (National Comprehensive Cancer Network), the United Kingdom (National Institute for Health and Care Excellence), Japan (Japanese Urological Association) and the International Consultation on Bladder Cancer (ICUD). We compare and contrast the different guidelines and the evidence on which their recommendations are based.
| Type: | Article |
|---|---|
| Title: | Management of non-muscle invasive bladder cancer: a comprehensive analysis of guidelines from the United States, Europe and Asia |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ctrv.2016.05.002 |
| Publisher version: | http://dx.doi.org/10.1016/j.ctrv.2016.05.002 |
| Language: | English |
| Additional information: | Copyright © 2016 Elsevier Ltd. All rights reserved. This is an uncorrected proof version; the final published article is available from the publisher's website at http://www.sciencedirect.com/science/article/pii/S0305737216300202 |
| Keywords: | Bladder cancer, Consensus guidelines, Non-muscle invasive bladder cancer, Recommendations, Review |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1497714 |
Archive Staff Only
 |
View Item |
